Here are the papers highlighted by our journals' Editor-in-Chiefs for October 2025.
Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonist
Brian Lord et al.
SGLT2 inhibitors and their influence on iron metabolism in the context of inflammation
Helene G. Meyer et al.
Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept study
Jort S. A. van der Geest
